Biblio Discovery — Demo Discovery Service

14 results for "Sarah Nersesian"

Showing 1–14 · 0.42 seconds · RSS

  1. Journal Article

    Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer

    Sarah Nersesian; Haley Glazebrook; Jay Toulany et al.

    Frontiers in Immunology, Vol. 10 · 2019 · English · DOAJ Scopus

    Ovarian cancer (OC) is diagnosed in ~22,000 women in the US each year and kills 14,000 of them. Often, patients are not diagnosed until the later stages of disease, when treatment options are limited, highlighting the urgent need for new and improved therapies for precise cancer control. An…

  2. Journal Article

    The Tumor Immune Contexture of Prostate Cancer

    Natasha Vitkin; Sarah Nersesian; David Robert Siemens et al.

    Frontiers in Immunology, Vol. 10 · 2019 · English · DOAJ Scopus

    One in seven men in North America is expected to be diagnosed with prostate cancer (PCa) during their lifetime (1, 2). While a wide range of treatment options including surgery, radiation, androgen deprivation and chemotherapy have been in practice for the last few decades, there are limited…

  3. Journal Article

    The Journey to a Successful Illustrated Review

    Sarah Nersesian; Michelle Sholzberg; Mary Cushman et al.

    Research and Practice in Thrombosis and Haemostasis, Vol. 6 No. 4 · 2022 · English · DOAJ Scopus

    Abstract Illustrated review articles, rooted in scientific rigor, are made up of “capsules” or panels of visuals that together provide an up‐to‐date overview of a topic. Illustrated reviews aim to provide a more accessible format than traditional written reviews to facilitate more effective…

  4. Journal Article

    DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes

    Thiago Vidotto; Sarah Nersesian; Charles Graham et al.

    Journal for ImmunoTherapy of Cancer, Vol. 7 No. 1 · 2019 · English · DOAJ Scopus

    Abstract Background Molecular subtyping of urothelial cancer (UC) has significantly advanced the understanding of bladder tumor heterogeneity and development of prognostic and predictive biomarkers. Evolving evidence across cancers strongly suggests that tumor immunoediting has a profound impact on…

  5. Journal Article

    Killer instincts: natural killer cells as multifactorial cancer immunotherapy

    Sarah Nersesian; Emily B. Carter; Stacey N. Lee et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    Natural killer (NK) cells integrate heterogeneous signals for activation and inhibition using germline-encoded receptors. These receptors are stochastically co-expressed, and their concurrent engagement and signaling can adjust the sensitivity of individual cells to putative targets. Against…

  6. Journal Article

    Investigating the STING Pathway to Explain Mechanisms of BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications

    Madhuri Koti; Stephen Chenard; Sarah Nersesian et al.

    Bladder Cancer, Vol. 5 · 2019 · English · DOAJ Scopus

    Background: Intravesical Bacillus Calmette Guerin (BCG) has been the gold standard immunotherapy to treat high risk non-muscle invasive bladder cancer (NMIBC) for over 40 years. Attenuation of Mycobacterium bovis for clinical use as BCG results in loss of its ability to activate the “Stimulator of…

  7. Journal Article

    Preparation of mitochondrial damage-associated molecular patterns from mouse liver tissue

    Lauren P. Westhaver; Sarah Nersesian; Adam Nelson et al.

    STAR Protocols, Vol. 3 No. 4 · 2022 · English · DOAJ Scopus

    Summary: Mitochondrial damage-associated molecular patterns (mitoDAMPs) are released from cells dying uncontrolled, non-apoptotic deaths, usually secondary to disease or trauma. Here, we describe preparation of mitoDAMPs from mouse liver, but this protocol can be adapted for preparation of…

  8. Journal Article

    NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis

    Sarah Nersesian; Sarah L. Schwartz; Stephanie R. Grantham et al.

    Translational Oncology, Vol. 14 No. 1 · 2021 · English · DOAJ Scopus

    The immune landscape of a tumor is highly connected to patient prognosis and response to treatment, but little is known about how natural killer (NK) cells predict overall survival (OS) among patients with solid tumors. We present the first meta-analysis on NK cell infiltration into solid tumors as…

  9. Journal Article

    Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models

    Daniel Newsted; Sunandan Banerjee; Kathleen Watt et al.

    OncoImmunology, Vol. 8 No. 2 · 2019 · English · DOAJ Scopus

    Epithelial ovarian cancer (EOC) is a leading cause of cancer-related death in women. EOC is often diagnosed at late stages, with peritoneal metastases and ascites production. Current surgery and platinum-based chemotherapy regimes fail to prevent recurrence in most patients. High levels of…

  10. Journal Article

    Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment

    Dalia Ibrahim; Melanie Grondin; Kristianne Galpin et al.

    Frontiers in Immunology, Vol. 16 · 2025 · English · DOAJ Scopus

    IntroductionOvarian cancer is the most lethal gynecological malignancy. Deepening our knowledge of the interactions within the tumor microenvironment (TME) is important for discovering new targeted treatment strategies. Transglutaminase 2 (TG2) is a protein implicated in many biological and…

  11. Journal Article

    Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages

    Sarah Nersesian; Riley J. Arseneau; Jorge P. Mejia et al.

    Frontiers in Immunology, Vol. 14 · 2024 · English · DOAJ Scopus

    BackgroundFor patients with high grade serous carcinoma of the ovary (HGSC), survival rates have remained static for the last half century. Despite the presence of tumor mutations and infiltration of immune cells, existing immunotherapies have achieved little success against HGSC. These…

  12. Journal Article

    Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma

    Riley J. Arseneau; Jorge P. Mejia; Sarah Nersesian et al.

    Frontiers in Immunology, Vol. 16 · 2025 · English · DOAJ Scopus

    BackgroundPancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers and has limited options for treatment. Low immune infiltration, desmoplastic stroma, and poor tumour immunogenicity are all expected to contribute to PDAC’s rapid progression and limited response to existing…

  13. Journal Article

    Mitochondrial DNA levels in perfusate and bile during ex vivo normothermic machine correspond with donor liver quality

    Lauren P. Westhaver; Sarah Nersesian; Riley J. Arseneau et al.

    Heliyon, Vol. 10 No. 5 · 2024 · English · DOAJ Scopus

    Ex vivo normothermic machine perfusion (NMP) preserves donor organs and permits real-time assessment of allograft health, but the most effective indicators of graft viability are uncertain. Mitochondrial DNA (mtDNA), released consequent to traumatic cell injury and death, including the…

  14. Journal Article

    THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer

    Olivia L. Walker; Marie-Claire D. Wasson; Vishnupriyan Kumar et al.

    Biomarker Research, Vol. 13 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Breast cancer remains the most prevalent cancer among women, with hormone receptor-positive (HR +) tumors accounting for approximately 70% of breast cancer cases. While the immune checkpoint inhibitor (ICI) anti-programmed cell death 1 (PD-1) pembrolizumab has demonstrated efficacy in…